Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53

被引:325
作者
Bialik, S
Geenen, DL
Sasson, IE
Cheng, R
Horner, JW
Evans, SM
Lord, EM
Koch, CJ
Kitsis, RN
机构
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MED CARDIOL, BRONX, NY 10461 USA
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT CELL BIOL, BRONX, NY 10461 USA
[3] UNIV PENN, SCH MED, DEPT RADIAT ONCOL, PHILADELPHIA, PA 19104 USA
[4] UNIV ROCHESTER, CTR CANC, ROCHESTER, NY 14627 USA
关键词
programmed cell death; ischemic heart disease; molecular genetics; knockout mice; nitroimidazoles;
D O I
10.1172/JCI119656
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Significant numbers of myocytes die by apoptosis during myocardial infarction. The molecular mechanism of this process, however, remains largely unexplored. To facilitate a molecular genetic analysis, we have developed a model of ischemia-induced cardiac myocyte apoptosis in the mouse. Surgical occlusion of the left coronary artery results in apoptosis, as indicated by the presence of nucleosome ladders and in situ DNA strand breaks. Apoptosis occurs mainly in cardiac myocytes, and is shown for the first time to be limited to hypoxic regions during acute infarction. Since hypoxia-induced apoptosis in other cell types is dependent on p53, and p53 is induced by hypoxia in cardiac myocytes, we investigated the necessity of p53 for myocyte apoptosis during myocardial infarction. Myocyte apoptosis occurs as readily, however, in the hearts of mice nullizygous for p53 as in wild-type littermates. These data demonstrate the existence of a p53-independent pathway that mediates myocyte apoptosis during myocardial infarction.
引用
收藏
页码:1363 / 1372
页数:10
相关论文
共 36 条
  • [21] Myocardial ischemia and reperfusion: A murine model
    Michael, LH
    Entman, ML
    Hartley, CJ
    Youker, KA
    Zhu, J
    Hall, SR
    Hawkins, HK
    Berens, K
    Ballantyne, CM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (06): : H2147 - H2154
  • [22] MIYASHITA T, 1995, CELL, V80, P293
  • [23] MIYASHITA T, 1994, ONCOGENE, V9, P1799
  • [24] MIYASHITA T, 1994, CANCER RES, V54, P3131
  • [25] Apoptosis in myocytes in end-stage heart failure
    Narula, J
    Haider, N
    Virmani, R
    DiSalvo, TG
    Kolodgie, FD
    Hajjar, RJ
    Schmidt, U
    Semigran, MJ
    Dec, GW
    Khaw, BA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (16) : 1182 - 1189
  • [26] Rizk MM, 1996, CIRCULATION, V94, P2754
  • [27] MOLECULAR AND BIOCHEMICAL REPROGRAMMING OF ONCOGENESIS THROUGH THE ACTIVITY OF PROOXIDANTS AND ANTIOXIDANTS
    SCHWARTZ, JL
    ANTONIADES, DZ
    ZHAO, SC
    BERTRAM, J
    PACKER, L
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1993, 686 : 262 - 279
  • [28] SEARLE J, 1982, PATHOL ANNU, V17, P229
  • [29] P53 - A CELL-CYCLE REGULATOR ACTIVATED BY DNA-DAMAGE
    SELIVANOVA, G
    WIMAN, KG
    [J]. ADVANCES IN CANCER RESEARCH, VOL 66, 1995, 66 : 143 - 180
  • [30] SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791